查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1957523

2026年全球維生素C市場報告

Obeticholic Acid Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，奧貝膽酸市場發展迅速。預計該市場將從2025年的10.1億美元成長到2026年的11.4億美元，複合年成長率（CAGR）為12.9%。過去幾年的成長主要歸功於以下幾個方面：用於治療原發性膽汁性膽管炎的臨床核准、肝病診斷率的提高、肝病專科診所的擴張、人們對膽汁酸調節療法的認知不斷提高以及肝病專科藥物的增多。

預計未來幾年奧貝膽酸市場將快速成長，到2030年將達到18.4億美元，複合年成長率（CAGR）為12.7%。預測期內的成長要素包括非酒精性脂肪性肝炎（NASH）患者數量的增加、肝病治療產品線的擴展、診斷篩檢的進步、肝病研究投入的增加以及口服肝病療法在全球範圍內的普及。預測期內的主要趨勢包括慢性肝病盛行率的上升、FXR促效劑療法的廣泛應用、對緩解疾病肝病療法的日益關注、非酒精性脂肪性肝炎（NASH）研究的擴展以及口服肝病療法的增加。

預計未來幾年，肝病發生率的上升將推動奧貝膽酸需求的成長。肝病是一組損害肝臟正常功能的疾病。肝病發生率的上升主要歸因於過量飲酒，過量飲酒會損害肝細胞並導致器官功能障礙，進而可能引發肝炎、肝硬化和肝功能衰竭。奧貝膽酸透過活化法尼醇X受體（FXR）來幫助肝病患者。 FXR能夠抑制膽汁酸的積累，減輕肝臟炎症，延緩纖維化的進展，最終改善肝功能。例如，根據英國政府機構「健康改善與不平等」（Health Improvement and Inequality）於2024年12月發布的報告，2023年因酒精性肝病導致的過早死亡人數增加了3.6%，達到5984人（2022年為5776人）。因此，肝病盛行率的上升正在推動奧貝膽酸市場的擴張。

在奧貝膽酸領域主要企業正致力於開發創新治療方法，例如法尼醇X受體（FXR）促效劑，以加強肝病管理並改善患者預後。法尼醇X受體（FXR）促效劑是能夠刺激FXR的化合物，FXR是一種核受體，在調節肝臟膽汁酸代謝、發炎和纖維化方面發揮關鍵作用。 FXR促效劑有助於改善肝功能，並用於治療原發性膽汁性膽管炎（PBC）和非酒精性脂肪性肝炎（NASH）。例如，2024年2月，總部位於美國的生物製藥公司Intercept Pharmaceuticals宣布，美國食品藥物管理局（FDA）已接受其用於治療原發性膽汁性膽管炎（PBC）的藥物Ocaliva的補充新藥申請（sNDA）。 FDA 接受奧貝膽酸（Ocaliva）的補充新藥申請（sNDA）代表監管方面的重大進展，證實了其在治療原發性膽汁性膽管炎（PBC）方面的臨床療效。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球維生素C酸市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術、循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 慢性肝病盛行率不斷上升
    • FXR促效劑療法的擴展
    • 人們越來越關注緩解疾病肝臟療法
    • 非酒精性脂肪性肝炎（NASH）研究的擴展
    • 口服肝臟治療藥物使用增加

第5章 終端用戶產業市場分析

  • 肝病專科醫院
  • 肝病專科診所
  • 三級醫療醫院
  • 胃腸病中心
  • 專科藥房

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球維生素C市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球奧貝膽酸市場規模、對比及成長率分析
  • 全球維生素C市場表現：規模與成長，2020-2025年
  • 全球維生素C市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 依產品類型
  • 速釋片、緩釋片、薄膜衣片
  • 透過分銷管道
  • 醫院藥局、零售藥局、網路藥局
  • 透過使用
  • 原發性膽汁性肝炎、非酒精性脂肪性肝炎及其他適應症
  • 依類型細分：速釋片
  • 標準口服片劑，低劑量片劑
  • 按類型細分：緩釋片
  • 徐放錠、1日1回投与用最適放出錠
  • 按類型細分：膜衣錠
  • 掩味片，腸溶片

第10章 區域與國別分析

  • 全球維生素C市場：依地區分類，歷史資料及預測（2020-2025年、2025-2030年、2035年）
  • 全球維生素C市場：依國家分類，歷史資料及預測（2020-2025年、2025-2030年、2035年）

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 維生素C市場：競爭格局及市場佔有率，2024年
  • 維生素C市場：公司估值矩陣
  • 維生素C市場：公司概況
    • Intercept Pharmaceuticals Inc.
    • Genfit
    • Gilead Sciences Inc.
    • Pfizer Inc.
    • Bayer AG

第37章 其他大型企業和創新企業

  • Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi SA

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年維生素C市場：提供新機會的國家
  • 2030年維生素C市場：提供新機會的市場
  • 2030年維生素C市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH5MOACI03_G26Q1

Obeticholic acid is a drug mainly prescribed for managing liver conditions, particularly in patients with primary biliary cholangitis (PBC), a long-term liver disorder. It is a synthetic bile acid that functions by stimulating a receptor known as the farnesoid X receptor (FXR), which aids in controlling bile acid synthesis, supporting liver function, and reducing inflammation.

The primary product forms of obeticholic acid include tablets, capsules, and other variants. Tablets are solid dosage forms intended for easy oral administration. The drug is distributed through multiple channels such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to manage nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.

Tariffs have affected the obeticholic acid market by increasing the cost of imported active pharmaceutical ingredients, intermediates, and excipients used in bile acid-based therapies. These impacts have been most pronounced in specialty liver drug segments, particularly in north america and europe. Asia-pacific manufacturers have faced procurement delays and cost pressures. However, tariffs have supported localized API production and formulation, improving supply continuity.

The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including obeticholic acid industry global market size, regional shares, competitors with a obeticholic acid market share, detailed obeticholic acid market segments, market trends and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obeticholic acid market size has grown rapidly in recent years. It will grow from $1.01 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to clinical approval for primary biliary cholangitis treatment, rising liver disease diagnosis, expansion of hepatology clinics, increased awareness of bile acid regulation therapies, growth in specialty liver drugs.

The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing NASH patient population, expansion of liver disease drug pipelines, improved diagnostic screening adoption, rising investment in hepatology research, global expansion of oral liver therapies. Major trends in the forecast period include rising prevalence of chronic liver diseases, increasing adoption of FXR agonist therapies, growing focus on disease-modifying liver drugs, expansion of nonalcoholic steatohepatitis research, increasing use of oral hepatology treatments.

The increasing incidence of liver diseases is expected to drive the demand for obeticholic acid in the coming years. Liver diseases are disorders that impair the liver's normal functioning. This rise in liver diseases is primarily attributed to excessive alcohol consumption, which can cause liver inflammation, cirrhosis, and liver failure by damaging liver cells and reducing the organ's ability to operate effectively. Obeticholic acid aids patients with liver diseases by activating the farnesoid X receptor (FXR), which lowers bile acid accumulation, diminishes liver inflammation, and slows the progression of fibrosis, ultimately enhancing liver function. For example, in December 2024, the Office for Health Improvement and Disparities, a UK government department, reported that premature deaths from alcoholic liver disease rose by 3.6% in 2023, reaching 5,984, up from 5,776 in 2022. Consequently, the growing prevalence of liver diseases is contributing to the expansion of the obeticholic acid market.

Major companies operating in the obeticholic acid sector are focusing on developing innovative therapies, such as farnesoid X receptor (FXR) agonists, to enhance liver disease management and improve patient outcomes. A farnesoid X receptor (FXR) agonist is a compound that stimulates the FXR, a nuclear receptor that plays a key role in regulating bile acid metabolism, inflammation, and fibrosis in the liver. Farnesoid X receptor (FXR) agonists aid in improving liver function and are utilized in treating conditions like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For example, in February 2024, Intercept Pharmaceuticals Inc., a US-based biopharmaceutical firm, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat patients with primary biliary cholangitis (PBC). The FDA's acceptance of the supplemental New Drug Application (sNDA) for obeticholic acid (Ocaliva) represents a regulatory milestone toward confirming its clinical benefits in managing PBC.

In November 2023, Alfasigma, a pharmaceutical company based in Italy, acquired Intercept Pharmaceuticals, Inc. for USD 19.00 per share in cash. Through this acquisition, Alfasigma seeks to enhance its presence in the U.S. and broaden its portfolio in gastroenterology and hepatology. Intercept Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company dedicated to developing therapies for rare and serious liver diseases, including primary biliary cholangitis (PBC), with its leading product being Ocaliva.

Major companies operating in the obeticholic acid market are Intercept Pharmaceuticals Inc., Genfit, Gilead Sciences Inc., Pfizer Inc., Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

North America was the largest region in the Obeticholic Acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the obeticholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obeticholic Acid Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Immediate-Release Tablets; Modified-Release Tablets; Film-Coated Tablets
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
  • Subsegments:
  • 1) By Immediate-Release Tablets: Standard Oral Tablets; Low-Dose Strength Tablets
  • 2) By Modified-Release Tablets: Controlled Exposure Tablets; Once-Daily Optimized Release Tablets
  • 3) By Film-Coated Tablets: Taste-Masked Tablets; Gastrointestinal-Tolerant Tablets
  • Companies Mentioned: Intercept Pharmaceuticals Inc.; Genfit; Gilead Sciences Inc.; Pfizer Inc.; Bayer AG; Sumitomo Dainippon Pharma Co. Ltd.; Horizon Therapeutics; Alembic Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Ltd.; Lupin Limited; Zydus Cadila; Teva Pharmaceutical Industries Ltd.; WuXi AppTec; Viva Life Sciences; Omgene Life Sciences Pvt. Ltd.; Enanta Pharmaceuticals; Novo Nordisk A/S; AstraZeneca plc; Roche Holding AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Obeticholic Acid Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Obeticholic Acid Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Obeticholic Acid Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Obeticholic Acid Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Prevalence Of Chronic Liver Diseases
    • 4.2.2 Increasing Adoption Of Fxr Agonist Therapies
    • 4.2.3 Growing Focus On Disease-Modifying Liver Drugs
    • 4.2.4 Expansion Of Nonalcoholic Steatohepatitis Research
    • 4.2.5 Increasing Use Of Oral Hepatology Treatments

5. Obeticholic Acid Market Analysis Of End Use Industries

  • 5.1 Hepatology Hospitals
  • 5.2 Specialty Liver Clinics
  • 5.3 Tertiary Care Hospitals
  • 5.4 Gastroenterology Centers
  • 5.5 Specialty Pharmacies

6. Obeticholic Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Obeticholic Acid Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Obeticholic Acid Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Obeticholic Acid Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Obeticholic Acid Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Obeticholic Acid Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Obeticholic Acid Market Segmentation

  • 9.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immediate-Release Tablets, Modified-Release Tablets, Film-Coated Tablets
  • 9.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
  • 9.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications
  • 9.4. Global Obeticholic Acid Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Oral Tablets, Low-Dose Strength Tablets
  • 9.5. Global Obeticholic Acid Market, Sub-Segmentation Of Modified-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Controlled Exposure Tablets, Once-Daily Optimized Release Tablets
  • 9.6. Global Obeticholic Acid Market, Sub-Segmentation Of Film-Coated Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Taste-Masked Tablets, Gastrointestinal-Tolerant Tablets

10. Obeticholic Acid Market Regional And Country Analysis

  • 10.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Obeticholic Acid Market

  • 11.1. Asia-Pacific Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Obeticholic Acid Market

  • 12.1. China Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Obeticholic Acid Market

  • 13.1. India Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Obeticholic Acid Market

  • 14.1. Japan Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Obeticholic Acid Market

  • 15.1. Australia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Obeticholic Acid Market

  • 16.1. Indonesia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Obeticholic Acid Market

  • 17.1. South Korea Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Obeticholic Acid Market

  • 18.1. Taiwan Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Obeticholic Acid Market

  • 19.1. South East Asia Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Obeticholic Acid Market

  • 20.1. Western Europe Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Obeticholic Acid Market

  • 21.1. UK Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Obeticholic Acid Market

  • 22.1. Germany Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Obeticholic Acid Market

  • 23.1. France Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Obeticholic Acid Market

  • 24.1. Italy Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Obeticholic Acid Market

  • 25.1. Spain Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Obeticholic Acid Market

  • 26.1. Eastern Europe Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Obeticholic Acid Market

  • 27.1. Russia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Obeticholic Acid Market

  • 28.1. North America Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Obeticholic Acid Market

  • 29.1. USA Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Obeticholic Acid Market

  • 30.1. Canada Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Obeticholic Acid Market

  • 31.1. South America Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Obeticholic Acid Market

  • 32.1. Brazil Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Obeticholic Acid Market

  • 33.1. Middle East Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Obeticholic Acid Market

  • 34.1. Africa Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Obeticholic Acid Market Regulatory and Investment Landscape

36. Obeticholic Acid Market Competitive Landscape And Company Profiles

  • 36.1. Obeticholic Acid Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Obeticholic Acid Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Obeticholic Acid Market Company Profiles
    • 36.3.1. Intercept Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Genfit Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Obeticholic Acid Market Other Major And Innovative Companies

  • Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

38. Global Obeticholic Acid Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Obeticholic Acid Market

40. Obeticholic Acid Market High Potential Countries, Segments and Strategies

  • 40.1 Obeticholic Acid Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Obeticholic Acid Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Obeticholic Acid Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer